Nektar Therapeutics | NKTR - Przychody Ze Sprzedaży





Obroty Zmiana Data
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
ALKERMES USD 496.01M 103.1M 2026-06
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 8.62B 1.28B 2026-03
Baxter International USD 2.96B 260M 2026-06
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Biogen USD 2.74B 490M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cipla INR 71.19B 5.78B 2026-06
Dr.Reddys Laboratories INR 80.71B 5.25B 2026-06
Eisai JPY 205.43B 14.51B 2026-03
Eli Lilly USD 19.8B 500M 2026-03
Exelixis USD 610.8M 12.14M 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 8.41B 781M 2026-06
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 377M 74.76M 2026-03
Incyte USD 1.67B 400M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
MacroGenics USD 20.8M 20.43M 2026-03
Merck USD 16.29B 110M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Neurocrine Biosciences USD 959M 148M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 14.5B 3.08B 2026-03
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 730.8M 287.9M 2026-03
Takeda JPY 1.22T 130B 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06
Xencor USD 4.51M 23.73M 2026-03